CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to OCUL

Single intravitreal injection of axitinib hydrogel implant followed by a mock (sham) injection procedure at Week 24

Phase 3
Ocular Therapeutix, Inc. (OCUL)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Non-Proliferative Diabetic Retinopathy

View Full Landscape
Drug Information

Target Indication

Non-Proliferative Diabetic Retinopathy

Clinical Trial

NCT07235085

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.